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Abstract
Background: Sri Lanka achieved the WHO certificate as a malaria free country in September 2016, thus monitoring
of malaria transmission using sensitive and effective tools is an important need. Use of age-specific antibody
prevalence as a serological tool to predict transmission intensity is proven to be a cost effective and reliable
method under elimination settings. This paper discusses the correlation of four anti-malarial antibodies against vivax
and falciparum malaria with the declining transmission intensities in two previously high malaria endemic districts i.
e. Kurunegala and Moneragala of Sri Lanka.
Methods: Sera was collected from 1,186 individuals from the two districts and were subjected to standard ELISA
together with control sera from non-immune individuals to obtain Optical Density (OD) values for four anti-malarial
antibodies i.e. anti-MSP1 and anti-AMA1 for both Plasmodium vivax and Plasmodium falciparum. The sero-positive
samples were determined as mean OD + 3SD of the negative controls. The sero-prevalence was analyzed against the
demographic characteristics of the population. A simple reversible catalytic model was fitted into sero-prevalence data
to predict the sero-conversion and sero-reversion rates.
Results: Over 60% of the population was sero-positive for one or more antibodies except young children (<10 years).
The sero-prevalence was zero in young children and very low in young adults when compared to the older age
groups. The model developed for falciparum malaria that assumed the presence of a change in transmission was not
significant in the Kurunegala district although significant reduction in transmission was observed when the model was
used for P. vivax antibody data in that district. In Moneragala district however, all the serological markers indicated a
change in transmission that has occurred approximately 15 years ago.
Conclusions: Assessment of MSP1 and AMA1 anti-malarial antibodies of P. vivax and P. falciparum proved to be useful
indicators in predicting transmission under elimination settings as prevailed in Sri Lanka. The sero-conversion rates for
the two districts studied are shown to be very low or zero indicating the absence of active and/or hidden transmission
confirming a “true” state of elimination at least, in the two study districts in Sri Lanka.
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Background
Malaria remained as a major health burden throughout
history in Sri Lanka, with recurring epidemics every 3–
5 years. However, countrywide malaria incidence rates
started to decline during the past decade facilitated by
the application of intense control programs (Fig. 1). Sri
Lanka moved to the “Elimination” phase of malaria in
2013 with the last indigenous case reported in late 2012
[1, 2]. The present challenge is to maintain the status of
zero transmission and prevent re-introduction of the in-
fection since re-emergence of the disease remains a pos-
sibility. In this backdrop, accurate estimates of malaria
transmission are of immense importance and relevance.
Direct methods such as entomological inoculation rate
(EIR) or parasite prevalence are traditionally used as in-
dices for monitoring and evaluation of transmission [3],
but utility of these tools is limited in low transmission or
apparently zero transmission areas [4, 5], hence the
quest for more sensitive and accurate tools.
Malaria was considered as an endemic disease in the
dry zone of Sri Lanka, prior to year 2000, though its
transmission was considered as low and seasonal. It
peaked from December to March period during the
northeast monsoons and smaller peaks occurred in
concurrence with the southwest monsoon during June
to October. The malaria endemic dry zone, as recog-
nized traditionally, included mainly the northern, east-
ern and southeastern parts of the island with
occasional epidemics in the intermediate zone (i.e.
northwestern and western mountain slopes) [6]. The
annual parasite incidence rate (API) reported in Sri
Lanka declined markedly from 22.1 in 1999 to less
than one in 2011 achieving 99.9% reduction in con-
firmed infections [6].
Sri Lanka has remained free of malaria transmission
for the past 3 years and was certified as a state “free-of-
malaria” in September 2016 by the World Health
Organization (WHO) [7].
Standard molecular methods have failed so far to
demonstrate the presence of submicroscopic levels of
parasitaemias in previously endemic zones [8], though
doubts remains as to the accuracy and sensitivity of
available tools [2].
Serological markers are tools that have been recog-
nized as good indicators of malaria transmission inten-
sity under various malaria endemic settings with
significant correlation with EIR estimates [5, 9–11]. Age-
specific sero-prevalence data have also been used as evi-
dence of reduction in malaria transmission and malaria
elimination [4, 12–14]. Its robustness to detect short
term variations in malaria transmission, applicability
even in low transmission areas and the relatively
cheaper/simpler laboratory procedures involved make
this method attractive over other traditional methods
[5, 10]. Furthermore, the persistence of anti-malarial
antibodies for longer periods [15], enable predictions to be
made even in the absence of active transmission, hence its
potential utility in elimination settings. Sero-prevalence
reflects cumulative exposure to malaria and therefore be-
lieved to be less affected by seasonality and/or unstable
transmission [10, 16] making it more suitable for use in
predicting variations in transmission.
The modeling of age-specific antibody prevalence and
fitting the reversible catalytic sero-conversion model to
real data has been described for Plasmodium falciparum
(P. falciparum/P.f.) at varying transmission intensities
[10, 17]. However, it has not been well studied in areas
with Plasmodium vivax (P. vivax/P.v.) malaria transmis-
sion, though it is indeed the species that is more resist-
ant to elimination efforts [2]. Plasmodium vivax had
always been the more prevalent causative agent of mal-
aria in Sri Lanka according to past records [18].
Fig. 1 Number of malaria cases reported 1985–2008. National data on P. vivax, P. falciparum and total number of malaria cases reported from
1985 to 2008 is given
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Indigenous malaria cases in the island decreased after
the year 2000 with a prominent reduction of the propor-
tion of P. falciparum cases. The number of falciparum
malaria cases were less than five during the years 2011
and 2012 whereas the total cases were 124 and 23 re-
spectively [2].
Anti-malarial antibodies anti-MSP1−19 (Merozoite
Surface Protein 119), anti-MSP2 (Merozoite Surface Pro-
tein 2) and anti-AMA1 (Apical Membrane Protein) have
been widely used in predicting medium and long term
variations of malaria transmission [4, 5, 10, 11]. How-
ever, the use of NANP (N-acetylneuraminic acid phos-
phatase) or CSP (Circumsporozoite Protein) appear to
be limited [19].
The main objective of this study was to assess the ability
to predict changes in malaria transmission by fitting age-
specific anti-malarial antibody prevalence to a reversible
catalytic model for both P. vivax and for P. falciparum
using two anti-malarial antibodies viz. anti-MSP1 and
anti-AMA1 (for both P. vivax and P. falciparum) which
were proven to be sustained at high levels in Sri Lankan
populations earlier [15].
Methods
Study area
The present study was conducted during December
2013–August 2014 in two previously malaria endemic
districts in Sri Lanka, namely Kurunegala (7.75°N, 80.25°E)
and Moneragala (6.66°N, 81.33°E) located in the dry zone
lowlands about 127 kilometers apart (Fig. 2). The monthly
temperature of the Kurunegala district averages above
30 °C while that of Moneragala is relatively low be-
tween 25–30 °C. The mean monthly rainfall in the
Kurunegala district varies from 62 to 400 mm with two
peaks in April–June (150–250 mm) and in October–
November (300–350 mm). Mean monthly rainfall of
the Moneragala district varies from 110 – 152 mm
with over 80% of rain received during the two rainy
seasons i.e. October – January and March – May.
Malaria transmission rates were high in both these
districts until the year 2005 or so [18] when the API
declined drastically (Table 1).
Socio-demographic profile of the districts
Kurunegala district is considered “a more developed/ur-
banized area” with more municipal and urban areas
compared to the Moneragala district. Furthermore, 1.9%
of the population of the Kurunegala district is catego-
rized as “urban” while the entire population of the
Moneragala district is categorized under either “rural”
(98.1%) or “estate” (1.9%) population, the latter being the
resident labourers of areas with plantations (Table 2). By
2012 Moneragala had 21.6% of its population migrated
from other districts (i.e. mainly from Badulla and
Hambantota districts, which are considered as malaria
endemic zones). In Kurunegala district however, the mi-
grant population (12.1%) was from Kandy, Gampaha and
Puttalam districts where malaria was not abundant (ex-
cept in Puttalam). In summary the socio-demographic
characteristics differ between the two districts, with the
Kurunegala district having a more urbanized population
with a higher population density and a considerable per-
centage of the community engaged in services and in-
dustries when compared to the Moneragala district,
where the population is more of a rural nature engaged
in agricultural activities (Table 2).
Sampling
All the District Secretariat (DS) divisions in the two dis-
tricts (i.e. 30 from Kurunegala and 11 from Moneragala)
were initially included in the sampling frame. Multi
stage cluster sampling was used in a non- random basis
(to identify the initial clusters) and random basis (to
identify second stage clusters). Four DS divisions (out of
the 11 DS divisions) from Moneragala district and 12 DS
divisions (out of 30) from the Kurunegala district were
selected on the basis of the presence of District/Base
hospitals or Medical Officer of Health offices (Fig. 2).
Second stage clusters were determined after selecting
the initial clusters. Two Grama Niladhari (GN) divisions
were randomly selected from each selected DS division by
drawing lots (i.e. 8 and 24 GN divisions from Moneragala
and Kurunegala respectively). Identification of loca-
tions was done within the secondary clusters, after
obtaining the relevant area maps from the Division of
Survey and Mapping of the Department of Census
and Statistics, Sri Lanka [20]. Non random sampling
(quota sampling) was carried out to recruit individ-
uals for specific age groups.
Sample size calculation
The base sample size was manually calculated (based on
the district prevalence) at a prevalence of 83% (recorded
sero-prevalence in Moneragala district being 83% [15]),
and at 95% confidence level and with a 5% margin of
error. The final sample (n = 500 for each district) was
calculated after correcting the base sample size for dif-
ferences in design, contingencies, laboratory errors etc.
An approximate sample size of 500 also warrants a 50–
75% relative length of the 95% confidence interval for esti-
mating sero-conversion rate while studying Southeast Asia
populations with entomological inoculation rate (EIR)
equal to 0.01 [21]. Furthermore, a sample size of ~500
subjects per district seems sufficient to detect sudden
drops in transmission intensity occurred at least 10 years
ago under different epidemiological settings [22]. How-
ever, the selected sample size does not seem to detect
abrupt changes that may have occurred in the short-term
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with high statistical power. It is therefore, expected that
the sample sizes used in this study would be unable to de-
tect more than two points of changes (i.e., both short-
term and long-term changes) in the data.
The number of individuals to be included from each DS
division was calculated based on probability proportionate
to the size of the populations of each DS division.
Ethical considerations
Ethical clearance for this study was granted by the Ethics
Review Committee, Faculty of Medicine, University of
Colombo, Sri Lanka.
Table 1 Annual Parasitic Index (API) of Kurunegala and
Moneragala districts from 2000 - 2010
Year Annual Parasitic Index (API)
Kurunegala district Moneragala district
2000 1.0 – 10 >100
2005 0.1 – 1.0 0.1 – 1.0
2010 <0.1 0.1 – 1.0
Source: Premaratna et al. (2011)
1
1
3 4
57
6
8
10
119
4
2
3
2
12
Fig. 2 Maps of the study sites. Kurunegala district and Moneragala district. The selected DS divisions of the two districts are numbered and
highlighted. Twelve DS divisions were selected from Kurunegala district (i.e. 1. Galgamuwa, 2. Polpithigama, 3. Ganewatta, 4. Ibbagamuwa, 5.
Rideegama, 6. Panduwasnuwara, 7. Udabaddawa, 8. Kuliyapitiya West, 9. Kuliyapitiya East, 10. Narammala, 11. Weerambugedara and 12.
Bamunukotuwa). From Moneragala district 4 DS divisions were selected (i.e. 1. Moneragala, 2. Buttala, 3. Kataragama, 4. Thanamalwila)
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Sample collection
Blood samples were collected by house to house visits,
from people attending communal gathering places and
local health facilities. Prior approval to collect blood
samples from persons attending hospitals or from the
community was obtained from the relevant adminis-
trative bodies. The required numbers of samples were
collected from these selected individuals after obtain-
ing informed consent. Blood samples from children
under 12 years were collected from those who
attended the local hospitals and already bled for other
tests. Consent for minors was obtained from their
parents/guardians.
Data collection
Every individual who was recruited for the study was given
a unique identification number. All personal identifiers
(e.g. name, address, and contact numbers) were entered in
a data collection book. Other information i.e. age, gender,
history of past malaria attacks (during their lifetime) as
recalled by the individual and socio-economic data was
entered to the data collection sheets prepared under each
individual’s unique identification number.
Blood collection and processing
Two milliliters (mL) of blood was drawn by a trained
technician or a nurse. This was divided in to two tubes;
(1 mL each) one coated with EDTA (Ethylene Di-amine
Tetra-acetic Acid) and one plain tube, labeled with each
individual’s identification number. The samples in EDTA
tubes were stored in freezers at the end of blood collec-
tion sessions until transfer to the laboratory in Colombo,
where they were stored at −70 °C for future use. Blood
in the plain tube was allowed to clot for 4–5 h at 4 °C
and was centrifuged at 12,000 r.p.m. (rounds per mi-
nute) to separate the serum. Serum was carefully ex-
tracted to a separate eppendorf tube labeled with the
identification number and was sealed with parafilm.
These serum samples were stored in the freezers until
transfer to Colombo in frozen condition, in ice packs
and were stored at −20 °C until further use.
Standard ELISA to identify the sero-positive samples
A standard ELISA (Enzyme Linked Immuno-Sorbent
Assay) protocol described elsewhere [15] was used with
minor adjustments as follows.
Four selected malaria antigens which are described in
literature [5, 10, 17] were used in this ELISA i.e. MSP1−19-
Pf, MSP1−19-Pv (School of Life Science, University of
Edinburgh, United Kingdom); AMA1-Pf or AMA1-Pv
(Biomedical Primate Research Centre, The Netherlands).
ELISA plates (96 micro-well plates/Nunclon, Germany)
were coated with 50 micro liters (μL) of antigen with a
concentration of 0.5 μg/mL. Plates were incubated at 4 °C
overnight and were washed three times with Phosphate
Buffered Saline with 0.05% Tween 20 (PBS/T). To each
well 100 μL of diluted serum samples (1: 200 for MSP1−19
and 1: 400 for AMA1 in 2% skimmed milk in PBS/T) were
added. Each ELISA plate contained 46 test samples in du-
plicate, a known positive control in duplicate, a known
negative control and a blank well. The plates were incu-
bated at 4 °C overnight. They were washed three times in
PBS/T and 50 μL of horse radish peroxidase-conjugated
rabbit anti-human IgG (Sigma-Aldrich/Cat#A8792) di-
luted in 1: 2000 in PBS/T was added to each well. This
was incubated for 3 h at room temperature before wash-
ing three times in PBS/T. To each well 50 μL of o-
phenylenediamine dihydrochloride (OPD) substrate
solution (Sigma-Aldrich/Cat#P1526) (0.4 mg/mL in solv-
ent) was added. This was left for 15 min for the colour to
develop. The reaction was stopped by adding 25 μL of
2 M H2SO4 per well. Then the plates were read at 492 nm
using an ELISA micro-plate reader. The Optical Density
(OD) value for each well was recorded separately. Stand-
ard procedures were carried out to maintain the validity
of the protocols. The same positive control was included
in every ELISA plate and a chart was maintained to iden-
tify any significant deviations (+/− 2 standard deviations
Table 2 Socio-demographic profile of the two districts
Socio-demographic factor Kurunegala
district
Moneragala
district
Area 4,816 km2 5,636 km2
Percentage from the total population
of Sri Lanka (2012)
7.9% 2.2%
Population growth factor (2001–2012) 0.97 1.21
Population density Persons/km2 (2012) 350 82
Urban population 1.9% -
Rural population 97.7% 98.1%
Estate population 0.5% 1.9%
Number of housing units (2014) 2100 460
Percentage of houses with electricity 85.1% 69.4%
Percentage acquired higher education 18.5% 11.4%
Percentage not ever attended a school 3.7% 7.8%
Literacy 94% 91%
Labour force participation 57.8% 63.7%
Percentage of males in the labour force 78.1% 81.8%
Percentage of females in the labour force 41.2% 46.9%
Percentage of the labour force in
agriculture
35.0% 56.9%
Percentage of the labour force in industries 26.6% 13.0%
Percentage of the labour force in
government/private sector services
38.4% 30.1%
Economically active percentage
population (male/female)
60.8%,
39.2%
61.8%,
38.2%
Source: Labour Force Survey 2014, Annual Report and Final Report on
Population Census 2012; Department of Census and Statistics, Sri Lanka
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(SD)) of the OD value of the particular sample for
normalization of the data. Plots were obtained to check
cross reactivity (Additional files 1 and 2).
The baseline (cut-off values) for each antibody was de-
termined with OD values obtained with serum samples
of 16 non-exposed, non-immune apparently healthy in-
dividuals from Matara and Colombo districts (malaria
non-endemic areas) and the cut-off values were deter-
mined (as mean) OD + 3SD i.e. 0.1115 for MSP1-Pf,
0.168 for MSP1-Pv, 0.0411 for AMA1-PF and 0.054 for
AMA1-Pv) for positive and negative responses to each
antigen according to previously used methods [10].
Mathematical and statistical methods
The OD values for each test serum sample were entered
into an Excel data sheet together with other information
collected on the sample (e.g. location, age, gender, previ-
ous malaria exposure). The samples with an OD value
exceeding the cut-off value for each antibody was con-
sidered as sero-positive for the relevant antibody. The
total sero-prevalence, as well as gender and age specific
sero-prevalence was determined for each district, DS
division and GN division and was compared using Chi
squared test with SPSS V15.0 statistical software. Revers-
ible catalytic models were fitted to each sero-positivity
data using a Binomial-product distribution for the sam-
pling distribution and estimation methods based on
maximum likelihood principle [5, 10, 23]. In each ana-
lysis, sero-conversion and sero-reversion rates (SCR and
SRR, respectively) were estimated for each district first
assuming constant transmission intensity over time
(Model 1) and then assuming a change of transmission
intensity (Model 2). In the latter, the past and present
SCR and the time of change of transmission intensity
were estimated using the profile likelihood method.
Since models one and two are nested on each other, the
comparison of these models was performed using the
log-likelihood ratio test. A significance level of 5% was
used in this test. Finally, all statistical analysis was con-
ducted in the software package R (3.1.0); the respective
scripts are available from the authors upon request.
Results
Characteristics of the population
A total of 1,186 individuals were recruited from the
two districts (637 from Kurunegala and 549 from
Moneragala). The number of females (n = 469) recruited
from Kurunegala district was over three times higher than
the male participants (n = 150) but the number of males
(n = 263) was comparable to the number of females
(n = 286) in the Moneragala district. Gender of 18
participants from the Kurunegala district has not been re-
corded (Table 3). The proportion of males to females
recruited from the two districts was significantly different
(Chi = 96.54, p < 0.001).
Age of the study subjects ranged between 1–84 years
(mean = 43.31 year, median = 46 years) in Kurunegala
and 1–85 years (mean = 26.04 years, median = 23 years) in
Moneragala with mean and median ages of subjects in
Kurunegala being significantly higher than in Moneragala
(t = 15.74, df = 1184, p < 0.01 and Mann–Whitney U =
88597.5, p < 0.001). Mean age varied between 40.2–
49.07 years in the DS divisions of Kurunegala, while in the
DS divisions of Moneragala it ranged between 23.8–
27.3 years. Study participants were divided into 4 age
groups as follows: 1–5 years, 6–10 years, 11–20 years and
age higher than 20 years. Although the number recruited
for the fourth age group (age >20 years) was higher when
compared to the other age groups in all the DS divisions
in both districts, the deviation was not significant between
any of the DS divisions. Numbers of individuals recruited
in all age groups (except >20 years) were more in the
Moneragala district, when compared to the Kurunegala
district, (Table 3; Chi = 148.499, p < 0.001).
In the Kurunegala district 18.8% of the study population
recalled (by memory) having had one or more attacks of
malaria infections (either P. vivax or P. falciparum) in the
past, while in the Moneragala district the percentage of a
previous history of malaria was in 21.9%. Previous malaria
exposure was comparable between the two districts, with
relevant data not available from 102 individuals from the
Kurunegala district and 56 from Moneragala district
(Table 3; Chi = 0.523, p = 0.507).
Previous exposure was not significantly different be-
tween any of the DS divisions within Kurunegala district,
Table 3 Characteristics of the population
Kurunegala district Moneragala district p value
Total Number
of recruits
637 549
n (%) n (%)
Age Distribution
1-5 years 20 (3.1%) 71 (12.9%) p < 0.05
6-10 years 13 (2.0%) 65 (11.8%) p < 0.05
11-20 years 56 (8.7%) 112 (20.4)% p < 0.05
> 20 years 548 (86.0%) 301 (54.8)% p < 0.05
Gender
Males 150 (23.5%) 263 (47.9%) p < 0.05
Females 469 (73.6%) 286 (52.1%)
Not recorded 18 (2.8%) 0
Previous malaria exposure
Yes 120 (18.8%) 120 (21.9%) p = 0.507
No 415 (65.1%) 373 (67.9%)
Not recorded 102 (16%) 56 (10.2%)
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but it was significantly higher in Kataragama DS division
when compared to the other DS divisions in the Moneragala
district (Chi = 8.133, p = 0.043).
The number of individuals with previous malaria
exposure was significantly higher in the 11–20 years
and >20 years categories in the Kurunegala district
(Chi = 10.358, p = 0.016) when compared to the other
age groups, but this pattern was not observed among the
participants from the Moneragala district. Previous expos-
ure to malaria was not significantly different between
males and females in either district (for Moneragala
Chi = 1.133, p = 0.287, for Kurunegala Chi = 7.53 p = 0.110).
Sero-prevalence of the population
Sero-prevalence of each antibody was calculated for each
district for each antibody. Over 60% of the population
was sero-positive for one or more anti-malaria anti-
bodies in both districts (Table 4). Higher proportion of
the population was sero-positive for AMA1 antigen in
both malaria species than to MSP1−19 antigen (Table 4).
The proportion of sero-positive individuals for each of
the four tested anti-malaria antibodies was significantly
higher in Moneragala with the odds of being sero-
positive in Moneragala being1.4 – >5 times higher when
compared to Kurunegala (p < 0.05) (Table 4).
Within each district, sero-prevalence did not signifi-
cantly differ between any of the DS divisions in either
district. Sero – prevalence of males and females in
Moneragala districts were comparable. However, the
sero prevalence between sexes in the Kurunegala district
showed a higher prevalence in males, the differences of
which were marginally significant for AMA1-Pf (p = 0.031)
and for any Pv (p = 0.044)/any Pf (p = 0.045) antibodies
(Chi square Test).
The sero-prevalence of the subjects in age groups 1–5
years and 6–10 years were significantly lower, when
compared to the values of the individuals age > 11 years
(11–20 year age group and > 20 year age group) for all
antibodies in Kurunegala district (p < 0.01, Chi square
test). In Moneragala district, this difference was even
more prominent with the sero-prevalence rates being
markedly low in younger age groups up to 20 years
(p < 0.01, Chi square test).
Over 50% with a history of previous exposure to mal-
aria were sero-positive for AMA1 antibodies in both dis-
tricts (54.2% for P. vivax, 55.8% for P. falciparum in
Kurunegala district and 59.2% for P. vivax, 56.7% for P.
falciparum in Moneragala district). However, the sero –
prevalence rate for MSP1−19 antigen was relatively lower
among individuals with history of previous exposure in
Kurunegala district (i.e. 25.8% for P. vivax, 31.7% for P.
falciparum), when compared to those in Moneragala
district (53.3% for P. vivax, 51.7% for P. falciparum).
Though the antibody prevalence for either vivax or fal-
ciparum antigen, was high (>55%) in individuals with
history of previous exposure in both districts, the associ-
ation between sero-positivity and history of malaria ex-
posure by recall was relatively poor and was not
statistically significant for either district (Chi square test/
Phi-Cramer’s V statistics).
Sero – prevalence as an indicator of malaria transmission
intensity
Changes in transmission intensity were identified for the
two districts, with regard to MSP1−19 -Pf, MSP1−19-Pv,
AMA1-Pf and AMA1-Pv antibodies separately (Table 5).
The population was sub-divided in to age groups with
intervals of 20 years i.e. 1–20 years, 21–40 years, 41–60
years and 61–80 years. The data was tested using two
models based on assumptions (a) presence of a single
force of infection (Model 1) and (b) in the presence of
changes in transmission (Model 2).
The results obtained for the Kurunegala district using
the reversible catalytic model were with several discrep-
ancies especially with Model two that assumed the pres-
ence of a change in transmission. The results were
incompatible with the observed data in contrast to the
outcome of Model one which indicated a single force of
infection with a sero-conversion rate (SCR) of 0.0079-yr
and a sero-reversion rate (SRR) of 0.0048-yr for MSP1−19
and a SCR of 0.0785and a SRR of 0.0608 for AMA1. Al-
though model two indicated a significant change in
transmission when P. vivax data were considered, the
probable time point of such a change failed to overlap,
(with time point estimated as 30 years whenMSP1-Pv data
was used and 5 years with AMA1-Pv data) (Table 5).
The change of transmission for Moneragala district ap-
pears to have occurred for P. falciparum approximately
10–14 years and approximately 15 years ago for P. vivax
(Fig. 3). The annual SCR decreased from 0.0192 – 0.0011
per year according to MSP1−19 data and from 0.1749 –
0.0231according to AMA1 data for falciparum malaria
and from 0.1312 – 0.0022 per year according to MSP1−19
Table 4 Sero-prevalence of tested antibodies
Sero-prevalence (%) p-value OR (CI)
Kurunegala Moneragala
MSP1-Pf 25.5 64.5 <0.001 5.31 (4.22,6.69)
MSP1-Pv 32.3 45.7 <0.001 1.76 (1.42,2.19)
AMA1-Pf 54.1 61.8 0.005 1.37 (1.11,1.70)
AMA1-Pv 52.9 61.3 0.001 1.41 (1.14,1.75)
Either Pf antibody 64.9 68.3 0.206 1.16 (0.93,1.45)
Either Pv antibody 63.8 65.1 0.664 1.06 (0.85,1.32)
Sero-prevalence for each tested antibody is compared between the two
districts using the chi square test. The p-values and the odds ratios (calculated
in relation to the Moneragala district) with 95% CI are indicated
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data and from 0.1998 – 0.0256 according to AMA1 data
for vivax malaria (Table 5).
Sero-conversion was also calculated using the sero-
positivity for any falciparum/any vivax anti-malaria anti-
body. This confirmed the time of change in transmission
in Moneragala district, to have occurred 10–14 years
and ~15 years prior to serum collection for falciparum
and vivax malaria respectively (Table 5). However, data
obtained for any P. vivax/any P. falciparum. antibody for
Kurunegala district failed to detect a changing point in
transmission.
Discussion
Age specific sero-prevalence is an index used to assess
the level of malaria endemicity in areas with both high
as well as low transmission [10, 19] and as evidence of
malaria elimination [4]. This study was conducted to as-
sess the ability of using this method to identify changes
in malaria transmission intensity retrospectively, in two
previously endemic areas where malaria transmission is
now considered virtually zero, in order to ascertain evi-
dence for cessation of transmission.
Since the results generated should be age dependent,
total random sampling could not be practiced when
selecting individuals for the study. Randomization was
practiced when selecting locations i.e. GN divisions from
the study area, but non-random quota sampling was car-
ried out for selecting individuals for specific age groups
to ensure that each age group had an adequate number
of study subjects to enable calculation of age-specific
sero-prevalence in order to fit the data into a simple re-
versible catalytic model. However, there are several dis-
advantages in this method although it gives a better
representation of certain groups within the population.
The major drawback of quota sampling is that it is im-
possible to detect a potential sampling error as it is not
a random sample and could lead to biased sampling.
This makes it risky to project the research findings to
the total population. Another limitation of quota sam-
pling is that although it might be representative of the
age, some other characteristics might not be represented
proportionally in the final sample group [24].
Without active transmission it was a challenge to
choose appropriate serological markers since there was
Table 5 Sero-Conversion Rates (SCR) for the two districts for each tested antibody
Kurunegala district MSP1-Pf AMA1-Pf MSP1-Pv AMA1-Pv Any Pf antigen Any Pv antigen
Model 1
SCR 0.0079
(0.003-0.009)
0.0785
(0.025-0.104)
0.0133
(0.054-0.197)
0.1058
(0.048-0.177)
0.0582
(0.048-0.177)
0.1114
(0.048-0.177)
SRR 0.0048
(10−13-1.307)
0.0608
(0.017-0.104)
0.0135
(0.003-0.124)
0.0890
(0.041-0.166)
0.0239
(0.004-5.43)
0.0576
(0.041-0.166)
Model 2
SCR past 0.0026
(0.0006-0.03)
0.0045
(0.0025-0.0127)
0.1212
(10−4-0.33)
167.372
(2.66-1282.19)
0.0099
(0.002-1.282)
104.896
(2.66-128.21)
SCR present <10−4 (10−7-1.041) 0.0597
(0.0369-0.0679)
0.0123
(10−4-0.04)
0.0368
(0.030-0.543)
0.0612
(0.003-5.43)
0.0340
(0.003-0.542)
SRR 0.0272 (0.006-0.06) <10−4 (10−7-105) 0.0327 (0.0-1.0) 0.1369 (10−7-8.111) <10−4 (10−8-105) 0.0930 (10−87-8.11)
Change point 12 11 30 5 13 5
p-value (LRT) 0.061 0.115 0.015 0.049 0.087 0.058
Moneragala district
Model 1
SCR 0.0665 (0.0131-0.188) 0.0548 (0.053-0.689) 0.0309 (10−3-1.36) 0.0536 (0.005-0.68) 0.0751 (0.04-0.177) 0.0653 (0.0091-0.13)
SRR <10−4 (10−7-5.59) <10−4 (10−8-1.88) <10−4 (10−41-2.97) 0.0003 (10−89-1.88) <10−4 (10−5-0.166) <10−4 (10−41-2.97)
Model 2
SCR past 0.0192
(0.0050-0.0765)
0.1749
(0.022-0.35)
0.1312
(0.02-0.4)
0.1998
(0.022-0.35)
0.2572
(0.002-1.28)
0.2935
(0.022-0.49)
SCR present 0.0011 (10−23-0.846) 0.0231 (0.003-0.129) 0.0022 (10−4-0.0026) 0.0256 (0.0035-0.129) 0.0268 (0.003-5.43) 0.0251 (10−4-0.269)
SRR <10−4 (10−23-1.085) 0.0026 (10−67-0.149) 0.0046 (10−7-3.48) 0.0038 (10−67-1.49) <10−4 (10−87-8.11) 0.0002 (10−7-3.48)
Change point 10 14 16 15 13 16
p-value (LRT) <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
SCR was calculated assuming constant transmission intensity (Model 1) and a change of transmission intensity at a given change point (Model 2) with 95%
Confidence Intervals within brackets. Sero-reversion rates (SRR) and log-likelihood associated with each model are also indicated. P-values refer to comparison
between models one and two using the log-likelihood ratio test (LRT)
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Fig. 3 (See legend on next page.)
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little evidence for the presence of specific anti-malarial
antibodies, except in the Moneragala district, where high
levels of anti-malarial antibodies i.e. MSP1−19, MSP2,
AMA1 for both P. vivax and P. falciparum and NANP
(tetra amino acid repeat of the CSP protein) for P. falcip-
arum were previously reported by the authors [15]. The
decay rates of MSP1−19 and AMA1 for falciparum malaria
have been shown through modeling experiments to be ex-
tremely low with antibodies having long half lives [10, 25].
AMA1 is a surface protein of merozoites which is highly
immunogenic hence can be easily detected. MSP1−19is
also described as a suitable immunological marker to
assess endemicity/change in transmission levels even
under low transmission conditions [10, 19].
Therefore, both MSP1−19 and AMA1 were selected to
model transmission intensity for P. falciparum using
age-specific sero-prevalence rates. MSP1−19 and AMA1
were also selected for P. vivax since it has been the more
prevalent causative species of malaria in Sri Lanka
through a major part of history and is the one that per-
sisted longer after elimination of P. falciparum a few
years earlier [2]. Both these antibodies appeared to be
long-lived as evidenced by previous studies conducted in
the Moneragala district [15].
The use of NANP as a suitable serological marker to
inform malaria transmission has been debated in low
transmission conditions [19]. NANP is a four amino acid
repeat region in the circumsporozoite protein (CSP).
Since sporozoites that enter the human body have a rela-
tively short life span in the blood due to their rapid entry
to the liver for further development or due to ingestion
by macrophages, the amount of antibodies developed
against CSP is believed to be very low especially in low
transmission settings [19]. Therefore, CSP is considered
as a less suitable and less reliable serological marker of
malaria endemicity when the EIR in the area is low [26].
Thus NANP was not selected as a marker to predict
transmission intensity in the Sri Lankan setting.
The number of female participants recruited from the
Kurunegala district was 3 times higher than of males. In
Kurunegala the blood samples were collected mainly by
visiting households during the morning hours when
males have already departed for work and from people
attending communal gathering places e.g. village weekly
fair, where the majority of attendees were females. These
reasons might have influenced the results with over
representation of female participants from the Kurune-
gala district. On the other hand the population from the
Moneragala district comprised mainly farmers, “chena”
cultivators or people who were engaged in their own
small-scale businesses, and thus the male participation
in the study was more or less comparable to that of fe-
males. These very reasons might also have accounted for
the differences in the mean and median ages of the two
districts; (mean and median ages in Kurunegala being 43
and 46 years while in Moneragala it was 26 and 23 years
respectively) as well as the differences in the number of
recruits in the different age groups.
Furthermore, this difference might have had an effect
on the reversible catalytic model since the number of
males included in the Kurunegala district was relatively
low. It appears that males tended to be sero positive
more than females though this difference was not statis-
tically significant.
Past history of the disease was determined by the par-
ticipants’ recall of memory. The data suggests that a his-
tory of previous exposure to malaria did not influence
the sero – prevalence rates in the two districts (or be-
tween the DS divisions within each district, except in the
Kataragama DS division of the Moneragala district).
Kataragama, which is situated in the south of the island,
is considered as a “Sacred City” with thousands of
people travelling on pilgrimage each year from various
parts of the country especially from the Northern areas,
where malaria used to be abundant. This might have
accounted for the higher transmission levels in this lo-
cality as recalled by the residents, when compared to
those living in other DS divisions. These factors as well as
differences in socio-economic structure in Moneragala,
which is more suitable for malaria transmission could ac-
count for the higher sero-prevalence in Moneragala when
compared to Kurunegala (Odds of Moneragala residents
being at risk being ~ three times more than those in
Kurunegala). This is further confirmed by the API in-
dices of the two districts, with API of Moneragala being
more than three times that of Kurunegala throughout the
period up to year 2000 [18].
Sero-prevalence for AMA1 antigen was higher than
that of MSP1−19 (for both P. vivax and P. falciparum).
AMA1 is considered to be highly immunogenic when
compared to the MSP1−19protein [10], which might ex-
plain the observations. Sero-prevalence among males in
(See figure on previous page.)
Fig. 3 Age specific sero-prevalence curves for each tested antibody. Age specific sero-prevalence curves for Kurunegala (a-b) and Moneragala
(c-d) districts for P. vivax and P. falciparum antibodies. Each graph shows the age specific sero-prevalence where the dots represent the observed
sero-prevalence when the age distributions were divided into the respective 10%-centiles. Reversible catalytic models assuming a constant
transmission intensity (red lines) and change in transmission intensity at a specific time (blue lines) were estimated for each tested antibody using
the maximum likelihood and the profile methods, respectively. P-values refer to the likelihood ratio tests for comparing the two reversible
catalytic models
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the Kurunegala district is significantly higher than that
of females (p < 0.05, Chi square test), probably due to
the differences in outdoor activities and attire style be-
tween the sexes. Such a pattern could not be observed in
Moneragala, however, probably due to the differences in
socio-economic factors and life style when compared
to Kurunegala. Sero-prevalence in younger age groups
i.e. <10 years was significantly low for all antibodies
(p < 0.01, Chi square test) indicating low transmission
levels in more recent years in both districts.
In the Kurunegala district however, a change in trans-
mission was not evident when P. falciparum data was
concerned and the modeled data indicated a single force
of infection. The sero-conversion rate calculated using P.
falciparum data was extremely low (0.0026-yr/0.0045-yr).
This could happen as results of very low transmission,
as described by Cook et al. [17]. As described, modeling
with increasing sero-positivity with age might be in-
appropriate in such an instance as the increase in sero-
prevalence with age could be negligible as well as a loss
of sero-positivity in older individuals is also a possibility
making it difficult to identify any change of point in
transmission [4]. Although the model with two transmis-
sion intensities could be used for P. vivax data (both
MSP1−19 and AMA1) the derived change of point in
transmission through the model was 5 years prior ac-
cording to AMA1 data and 30 years prior according to
MSP1 data. The difference in timelines indicated by the
two antibodies might be due to the differences in im-
munogenicity of the two antigens. AMA1 is said to be
more sensitive and immunogenic of the two and this
might account for the differences above. Furthermore,
this might also hint at a sub-microscopic transmission
that may have prevailed until 5 years prior to the sample
collection. Furthermore, different transmission patterns
for vivax and falciparum as evidenced by data is likely to
reflect the actual difference in transmission of the two
species observed over the years. However, the drop in fal-
ciparum transmission may not have occurred as suddenly
as that of P. vivax (Fig. 1), which might be the reason that
it was not evident in the sero-prevalence curves (Fig. 3).
The number of males included in the sample from
Kurunegala district was significantly lower compared to
females, and this might also have had an effect upon the
results obtained using the reversible catalytic model, since
males appear to have a higher chance of acquiring malaria
and P. falciparum is less common compared to P. vivax.
In the Moneragala district the change in transmission
was evident through the analysis of all tested antibodies;
but pointing at slightly different time points i.e. 10–14
years ago for falciparum malaria and approximately
15 years ago for vivax malaria. Furthermore, the predicted
sero-conversion rates (SCR past and SCR present) and
sero-reversion rates (SRR) were different for different anti-
body types which were observed in both districts (Table 5).
These differences might be the result of many factors,
including the differences in immunogenicity (e.g. AMA1
being more immunogenic compared to MSP1−19), sub-
class of antibody, half-life of the relevant antibody and
polymorphisms [19].
This study reveals a clear reduction in malaria trans-
mission in both these districts, especially in Moneragala
district where a marked decline in total district malaria
cases from 40,885 to 3705 in year 2000 (Fig. 4). In
Fig. 4 Malaria positive cases reported from the two studied districts (1997–2015). Number of total malaria cases reported from Moneragala and
Kurunegala districts during 1997–2015. Number of cases reported from 2005–2015 is indicated in the inset
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Kurunegala however, according to National data there
are two major drops of malaria incidence; one in year
2002 where the cases reduced from 2943 – 632 and in
year 2006–2007 where the number of cases reduced from
257 – 12 cases (Fig. 4) [18]. As the sample size is not suffi-
cient to detect more than two points change it could only
be detecting the change in transmission happened around
2007 (approximately 6 years prior to sample collection)
which is indicated by AMA1-Pv data (Table 5).
This reduction in transmission might be the outcome
of many factors, including socio-economical changes
(e.g. improved health facilities, uplifting of economical
status, improved housing, better road networks), eco-
logical (e.g. alterations of the breeding places) and inter-
ventions such as introduction of λ-Cyhalothrin in 1994,
shift in IRS strategy to targeted spray in 1996–97, Roll
Back Malaria initiative in 1999 and introduction of
artemisinin-based combination therapy in 2007 [6].
Information considered collectively demonstrates the
usefulness of serological markers to assess the endem-
icity under low malaria transmission conditions and its
potential for use as evidence for elimination of malaria,
particularly when combined with improved technology
to make this tool even more sensitive and accurate.
The study used only two recombinant antigens of each
Plasmodium species, which might be a limitation since at
individual level there are likely variations in immune re-
sponse to different parasite antigens. Thus there might
have been individuals in the study population who did not
show sero-positivity in spite of exposure to malaria. There-
fore, using a higher combinations of antigens to identify
sero-positive individuals might be a better approach [27].
A low number of sero-positive individuals in the youn-
ger age groups may have also limited the chance of de-
tecting significant changes in transmission over time. A
larger population of younger study subjects in the survey
would have increased the chances of getting amore sero-
positives within the younger age groups. Number of in-
dividuals that should be included in each age group was
calculate (quota sampling) when calculating the sample
size for each DS division to minimize this error. How-
ever, this had practical limitations due to difficulties in
getting blood from young children in the community as
malaria is not perceived as a threat in this community in
recent years. Therefore, in this study blood samples were
collected from younger children who attended govern-
ment hospitals and private health facilities, and who
were anyway bled to carry out other investigations,
which limited the numbers included.
Another possible limitation to this study may have
been the inadvertent inclusion of sero-positives who ac-
quired the disease following travel to a malaria endemic
country. If the travel history was not provided during
the surveys, this may have led to an over estimation of
the level of transmission using the serological markers.
Although unlikely, with present observations, it still re-
mains a possibility.
Cross reactivity with other parasitic antigens in the
ELISA may have also influenced the results. Donahue in
2000 reported a Toxoplasma homolog to the AMA1
antigen of the P. falciparum and similarly Gaffar in 2004
documented a protein of Babesia bovis which was hom-
ologous to P. falciparum AMA1 [28, 29]. However, since
the prevalence of such diseases in the Sri Lankan popu-
lation is low, such a bias on observed results could be
considered as negligible.
Another unlikely possibility is the cross-reactivity be-
tween MSP1−19/AMA1 of P. falciparum and P. vivax spe-
cies. Merozoite Surface Protein 1 (MSP1) and especially
Apical Membrane Antigen 1 (AMA1) are relatively con-
served between both P. vivax and P. falciparum [30, 31]
several studies have indicated that the cross-reactivity of
these antibodies between the two Plasmodia species is ei-
ther unlikely or very low [32, 33].
Conclusions
Age-specific sero – prevalence curves were proven to be
a useful tool in predicting malaria transmission intensity
in Sri Lanka where malaria elimination has been
achieved. The data suggests a low single force of trans-
mission in Kurunegala district for falciparum malaria
but hints a decline of vivax malaria starting 30 years ago.
It also suggests a possibility of a sub-microscopic level
transmission of Plasmodium vivax that may have pre-
vailed until recently. A drastic decline in local transmis-
sion in the Moneragala district was evident, beginning
approximately 10–15 years ago for both species and the
current rates of sero-conversion are extremely low or zero,
confirming the absence of active transmission.
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